Activation of AIM2 by hepatitis B virus results in antiviral immunity that suppresses hepatitis C virus during coinfection

J Virol. 2023 Oct 31;97(10):e0109023. doi: 10.1128/jvi.01090-23. Epub 2023 Oct 3.

Abstract

Clinical data suggest that Hepatitis C virus (HCV) levels are generally lower in Hepatitis B virus (HBV) co-infected patients, but the mechanism is unknown. Here, we show that HBV, but not HCV, activated absent in melanoma-2. This in turn results in inflammasome-mediated cleavage of pro-IL-18, leading to an innate immune activation cascade that results in increased interferon-γ, suppressing both viruses.

Keywords: AIM2; NK cells; hepatitis B virus; hepatitis C virus; monocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Coinfection* / immunology
  • Coinfection* / virology
  • DNA-Binding Proteins* / metabolism
  • Hepacivirus* / immunology
  • Hepatitis B virus* / immunology
  • Hepatitis B virus* / physiology
  • Hepatitis B* / complications
  • Hepatitis B* / immunology
  • Hepatitis B* / virology
  • Hepatitis C* / complications
  • Hepatitis C* / immunology
  • Hepatitis C* / virology
  • Humans
  • Immunity, Innate*
  • Inflammasomes / metabolism
  • Interferon-gamma / immunology

Substances

  • AIM2 protein, human
  • DNA-Binding Proteins
  • IL18 protein, human
  • Inflammasomes
  • Interferon-gamma